CliffBio
small molecule

BRICANYL

TERBUTALINE SULFATE

Loss of exclusivity—loss of exclusivity
CompanySANOFI AVENTIS US LLC

Drug detail

Brand nameBRICANYL
Active ingredientTERBUTALINE SULFATE
Strength0.2MG/INH
Dosage formAEROSOL, METERED
RouteINHALATION
ModalitySmall molecule
FDA approvalMarch 1985
Marketing statusDISCN

More from SANOFI AVENTIS US LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

BRICANYL patent cliff — loss of exclusivity — | CliffBio